Detalhe da pesquisa
1.
Pressure and flow properties of cannulae for extracorporeal membrane oxygenation II: drainage (venous) cannulae.
Perfusion
; 34(1_suppl): 65-73, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30966909
2.
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial.
Blood
; 121(23): 4647-54, 2013 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23616624
3.
Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation.
Eur J Haematol
; 87(2): 117-22, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21535157
4.
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial.
Lancet Oncol
; 11(10): 973-82, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20863761
5.
TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.
Int J Med Sci
; 5(2): 87-91, 2008 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-18414650
6.
International staging system for multiple myeloma.
J Clin Oncol
; 23(15): 3412-20, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15809451
7.
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation.
Haematologica
; 91(9): 1228-33, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16956822
8.
[Diagnosis and follow up of patients with small M components. With the view to avoid transformation to malignant disease]. / Diagnostik och uppföljning av patienter med små M-komponenter. Med sikte på att undvika transformation till malign sjukdom.
Lakartidningen
; 107(4): 176-9, 2010.
Artigo
em Sueco
| MEDLINE | ID: mdl-20333970
9.
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
Br J Haematol
; 147(1): 22-42, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19673884
10.
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
Haematologica
; 89(5): 520-7, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15136214
11.
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
Hematol J
; 5(6): 462-6, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15570285
12.
[Swedish executive officers' frustration over working conditions]. / Frustration over arbetsvillkoren hos svenska verksamhetschefer.
Lakartidningen
; 102(5): 318-20, 2005.
Artigo
em Sueco
| MEDLINE | ID: mdl-15754542
13.
Survival and years of life lost in different age cohorts of patients with multiple myeloma.
J Clin Oncol
; 28(9): 1599-605, 2010 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20177027
14.
[Patient-specific cost calculation--a good way to evaluate new therapeutic methods]. / Patientspecifik kostnadsberäkning--bra bas för att värdera nya behandlingsmetoder.
Lakartidningen
; 100(42): 3304-6, 2003 Oct 16.
Artigo
em Sueco
| MEDLINE | ID: mdl-14619039
15.
[Constant fear of liability reporting in physicians' everyday work. Impressions from interviews with physicians in Western Gotaland]. / Rädsla för HSAN-anmälan ständigt närvarande i läkares vardagsarbete. Intryck från intervjuer med läkare i Västra Götaland.
Lakartidningen
; 100(40): 3160-1, 2003 Oct 02.
Artigo
em Sueco
| MEDLINE | ID: mdl-14579669
16.
Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Ann Hematol
; 87(6): 467-74, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18351338
17.
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
Cancer
; 112(1): 129-35, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17973267
18.
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.
Blood
; 111(8): 4039-47, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18268097
19.
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.
Br J Haematol
; 133(4): 389-96, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16643445
20.
Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care.
Eur J Haematol
; 74(3): 185-93, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15693787